Purchase Order 75N98026P01078

The National Institute on Aging awarded a purchase order to CDI Laboratories Inc. for $20,178.74 on July 22, 2020, for Huprot Array Service. CDI Laboratories is a small disadvantaged business manufacturer based in Mayagüez, Puerto Rico. The order carries firm fixed price terms with no set-aside designation and an ultimate completion date of November 4, 2020. Place of performance is Mayagüez, Puerto Rico. The requirement addresses protein microarray analysis services, leveraging the awardee's...

<p>The National Human Genome Research Institute awarded a purchase order to CDI Laboratories Inc. for $24,000.00 on June 25, 2020, to analyze 40 serum samples using VirScan and HuScan PhIP-Seq package services. CDI Laboratories is a small disadvantaged business. Work is performed in Mayagüez, Puerto Rico. The order was issued under the Coronavirus COVID-19 National Interest Action Code with a firm fixed price and ultimate completion date of June 25, 2020.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to CDI Laboratories Inc. for $19,412.15 on October 26, 2021, for HuProt v4.0 protein arrays (quantity 16 at $1,058.16 each) to support COVID-19 autoantibody profiling research under the FY26 UDO Initiative. CDI Laboratories is a small disadvantaged business manufacturer. Performance occurs in Mayagüez, Puerto Rico. The order carries firm fixed-price terms and was scheduled for completion by November 26, 2021.

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to CDI Laboratories Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract, valued at $23,999.72, is for CDI Laboratories to provide its proprietary human proteome microarray assay services to support biomedical research efforts, particularly in the areas of infectious...

This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to CDI Laboratories Inc. for $96,812.10. The contract is for the provision of 110 samples and bioinformatics analysis of serum samples using CDI's proprietary HuProt v4.0 protein arrays to support COVID-19 research. CDI Laboratories is a small disadvantaged business that has received numerous prime federal contracts from NIH...

This is a $98,253.09 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to CDI Laboratories Inc., a small disadvantaged business manufacturer. The contract is for the provision of CDI's HuProt v4.0 Human Proteome Microarray, containing over 21,000 human proteins, as well as its VirScan viral antibody profiling and immuneprofiler antibody analysis services. This work supports biomedical research efforts,...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to CDI Laboratories Inc. for immuneprofiler analysis of 30 serum samples using CDI's HuProt microarrays. The purpose is to directly compare the sample data obtained from phage immunoprecipitation sequencing (PhIP-Seq). The contract has a period of performance from April 26, 2021 to April 25, 2022 and a potential value of $218,400.00. The award...

The National Institute of Mental Health (NIMH) awarded a $50,000.00 firm-fixed-price purchase order to CDI Laboratories Inc., a small disadvantaged business located in Mayagüez, Puerto Rico. The award is for CDI Laboratories' HuProt v4.0 Human Proteome Microarrays with Biospecimen Screening Service and Analysis. This non-competitive acquisition will support the NIMH's Translational Immunopsychiatry Unit (TIU) in autoantibody discovery and validation research, specifically screening for...

This firm-fixed-price purchase order contract was awarded to CDI Laboratories Inc., a small disadvantaged business, to provide its proprietary HUPROT V4.0 ARRAY protein microarray product and related antibody profiling and analysis services to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $121,379.50 contract supports biomedical research efforts, particularly in the areas of infectious diseases, heart/lung disorders, aging, and...

<p>The National Cancer Institute awarded a purchase order to Labcorp Early Development Laboratories Inc. for $34,449 on May 22, 2019. The 12-month testing services order has a firm fixed price and ultimate completion date of November 21, 2019. Work is performed in Madison, Wisconsin. The purchase order was issued without a set-aside designation and arose from a pre-solicitation opportunity posted April 24, 2019 with a May 9, 2019 deadline.</p>